The choice of alternative therapy depends on individual patient factors including renal function, cardiovascular risk profile, weight management goals, hypoglycaemia risk, and patient preferences, all of which should be discussed thoroughly with the GP or diabetes specialist team
Dont touch it
Formerly a researcher in thematics varying from cardiology to neurodegenerative diseases, she is now part of Long Long Life team and is involved in scientific writing and anti-aging research
Washington will require significant and ongoing support from its regional allies and partners to successfully deter Chinese adventurism and shore-up a stable strategic order in the Indo-Pacific
Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, et al
Due to the rapid renal clearance of small peptides like GLP-1, along with its deactivation by dipeptidyl peptidase 4 (DPP4), development of stable peptides, with an increased resistance to DPP4 was required ( The origin of GLP-1 and its physiological pathway was discovered in the 1980s by the decoding of nucleotide sequences of mammalian preproglucagons, the precursors of proglucagon ( When GLP-1 interacts with GLP-1R, this triggers cyclic adenosine monophosphate (cAMP) formation and initiates subsequent pathways ( 2 Methodology A structured literature search was conducted using PubMed/MEDLINE and Google Scholar, with the Boolean search string: (GLP-1 receptor agonist OR GLP-1RA) AND (multifaceted roles OR pleiotropic effects)